Stat3 promotes IL-10 expression in lupus T cells through trans-activation and chromatin remodeling
暂无分享,去创建一个
T. Rauen | G. Tsokos | V. Kyttaris | J. C. Crispín | C. Hedrich | Sokratis A. Apostolidis | A. Grammatikos | S. Apostolidis | Noe Rodriguez Rodriguez | C. Ioannidis | J. Crispín
[1] M. Kretzler,et al. Comparative Transcriptional Profiling of 3 Murine Models of SLE Nephritis Reveals Both Unique and Shared Regulatory Networks , 2013, PloS one.
[2] K. Sullivan,et al. Genetics and Epigenetics of Systemic Lupus Erythematosus , 2013, Current Rheumatology Reports.
[3] D. Ye,et al. Role of interleukin-10 and interleukin-10 receptor in systemic lupus erythematosus , 2013, Clinical Rheumatology.
[4] T. Rauen,et al. cAMP responsive element modulator: a critical regulator of cytokine production. , 2013, Trends in molecular medicine.
[5] Q. Lu,et al. Impaired DNA methylation and its mechanisms in CD4(+)T cells of systemic lupus erythematosus. , 2013, Journal of autoimmunity.
[6] V. Tesar,et al. Serum cytokine profile in patients with active lupus nephritis. , 2012, Cytokine.
[7] T. Rauen,et al. cAMP response element modulator α controls IL2 and IL17A expression during CD4 lineage commitment and subset distribution in lupus , 2012, Proceedings of the National Academy of Sciences.
[8] A. Rösen‐Wolff,et al. Biological properties and regulation of IL-10 related cytokines and their contribution to autoimmune disease and tissue injury. , 2012, Clinical immunology.
[9] G. Tsokos,et al. Epigenetic mechanisms in systemic lupus erythematosus and other autoimmune diseases. , 2011, Trends in molecular medicine.
[10] G. Tsokos,et al. The dysregulation of cytokine networks in systemic lupus erythematosus. , 2011, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[11] T. Rauen,et al. cAMP-responsive Element Modulator (CREM)α Protein Signaling Mediates Epigenetic Remodeling of the Human Interleukin-2 Gene , 2011, The Journal of Biological Chemistry.
[12] Y. Jiang,et al. Interleukin‐10 receptor expression and signalling were down‐regulated in CD4+ T cells of lupus nephritis patients , 2011, Clinical and experimental immunology.
[13] C. Bao,et al. Multidimensional Single Cell Based STAT Phosphorylation Profiling Identifies a Novel Biosignature for Evaluation of Systemic Lupus Erythematosus Activity , 2011, PloS one.
[14] JC Crispín,et al. IL-17-producing T cells in lupus nephritis , 2011, Lupus.
[15] J. Bream,et al. Dynamic DNA methylation patterns across the mouse and human IL10 genes during CD4+ T cell activation; influence of IL-27. , 2010, Molecular immunology.
[16] F. Gao,et al. Hypomethylation of IL10 and IL13 Promoters in CD4+ T Cells of Patients with Systemic Lupus Erythematosus , 2010, Journal of biomedicine & biotechnology.
[17] J. Bream,et al. Cell type-specific regulation of IL-10 expression in inflammation and disease , 2010, Immunologic research.
[18] E. Wagner,et al. Epidermal loss of JunB leads to a SLE phenotype due to hyper IL-6 signaling , 2009, Proceedings of the National Academy of Sciences.
[19] Peter O. Krutzik,et al. Stage Dependent Aberrant Regulation of Cytokine-STAT Signaling in Murine Systemic Lupus Erythematosus , 2009, PloS one.
[20] J. Andreu,et al. Monocytes and T lymphocytes contribute to a predominance of interleukin 6 and interleukin 10 in systemic lupus erythematosus , 2009, Cytometry. Part B, Clinical cytometry.
[21] Thomas Korn,et al. IL-17 and Th17 Cells. , 2009, Annual review of immunology.
[22] F. Yamasaki,et al. The Production of IL-10 by Human Regulatory T Cells Is Enhanced by IL-2 through a STAT5-Responsive Intronic Enhancer in the IL-10 Locus , 2008, The Journal of Immunology.
[23] J. Bream,et al. Stat4-dependent, T-bet-independent regulation of IL-10 in NK cells , 2008, Genes and Immunity.
[24] J. O’Shea,et al. Th17 cells: a new fate for differentiating helper T cells , 2008, Immunologic research.
[25] G. Tsokos,et al. Increased expression of STAT3 in SLE T cells contributes to enhanced chemokine-mediated cell migration , 2007, Autoimmunity.
[26] L. Pasquier,et al. Orphanet Journal of Rare Diseases , 2006 .
[27] G. Riemekasten,et al. T cell cytokine imbalance towards production of IFN‐γ and IL‐10 in NZB/W F1 lupus‐prone mice is associated with autoantibody levels and nephritis , 2006, Scandinavian journal of rheumatology.
[28] J. Renauld,et al. Interleukin-10 blockade corrects impaired in vitro cellular immune responses of systemic lupus erythematosus patients. , 2000, Arthritis and rheumatism.
[29] D. Alarcón-Segovia,et al. Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus. , 2000, Arthritis and rheumatism.
[30] D. Levy,et al. Stat Protein Transactivation Domains Recruit p300/CBP through Widely Divergent Sequences* , 1999, The Journal of Biological Chemistry.
[31] B. Groner,et al. p300/CREB-binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of Stat5, but does not participate in the Stat5-mediated suppression of the glucocorticoid response. , 1998, Molecular endocrinology.
[32] M. Hochberg,et al. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.
[33] J. Renauld,et al. Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity , 1995, Lupus.
[34] D. Alarcón-Segovia,et al. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus , 1995, The Journal of experimental medicine.
[35] A D GUNN,et al. Case of Anaphylaxis after Anaesthesia , 1943, British medical journal.
[36] G. Tsokos,et al. Transcriptional regulation of IL-2 in health and autoimmunity. , 2009, Autoimmunity reviews.